ASSESSMENT OF POTENTIAL TREATMENTS FOR DRUG-INDUCED RESPIRATORY DEPRESSION AND OVERDOSE TOXICITY. POP: SEPTEMBER 26, 2022 - SEPTEMBER 25, 2023. TASK O

NIH RePORTER · NIH · N01 · $102,721 · view on reporter.nih.gov ↗

Abstract

The objectives of this project are to determine the effects of experimental compounds on respiratory parameters in rodents or other species in models relevant to the opioid overdose crisis. Compounds may be tested alone for effects on respiration (stimulation or depression), or for their ability to modulate respiratory depressant effects of opioids and possibly other drugs of abuse.

Key facts

NIH application ID
10713095
Project number
75N95022D00019-0-759502200003-1
Recipient
LOVELACE BIOMEDICAL RESEARCH INSTITUTE
Principal Investigator
FADI XU
Activity code
N01
Funding institute
NIH
Fiscal year
2022
Award amount
$102,721
Award type
Project period
2022-09-26 → 2023-09-25